BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 16436662)

  • 1. A soluble BAFF antagonist, BR3-Fc, decreases peripheral blood B cells and lymphoid tissue marginal zone and follicular B cells in cynomolgus monkeys.
    Vugmeyster Y; Seshasayee D; Chang W; Storn A; Howell K; Sa S; Nelson T; Martin F; Grewal I; Gilkerson E; Wu B; Thompson J; Ehrenfels BN; Ren S; Song A; Gelzleichter TR; Danilenko DM
    Am J Pathol; 2006 Feb; 168(2):476-89. PubMed ID: 16436662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selectivity of BAFF/BLyS and APRIL for binding to the TNF family receptors BAFFR/BR3 and BCMA.
    Day ES; Cachero TG; Qian F; Sun Y; Wen D; Pelletier M; Hsu YM; Whitty A
    Biochemistry; 2005 Feb; 44(6):1919-31. PubMed ID: 15697217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B-cell subsets in blood and lymphoid organs in Macaca fascicularis.
    Vugmeyster Y; Howell K; Bakshi A; Flores C; Hwang O; McKeever K
    Cytometry A; 2004 Sep; 61(1):69-75. PubMed ID: 15351991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BAFF supports human B cell differentiation in the lymphoid follicles through distinct receptors.
    Zhang X; Park CS; Yoon SO; Li L; Hsu YM; Ambrose C; Choi YS
    Int Immunol; 2005 Jun; 17(6):779-88. PubMed ID: 15908449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BAFF/BLyS receptor 3 comprises a minimal TNF receptor-like module that encodes a highly focused ligand-binding site.
    Gordon NC; Pan B; Hymowitz SG; Yin J; Kelley RF; Cochran AG; Yan M; Dixit VM; Fairbrother WJ; Starovasnik MA
    Biochemistry; 2003 May; 42(20):5977-83. PubMed ID: 12755599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rescue of the mature B cell compartment in BAFF-deficient mice by treatment with recombinant Fc-BAFF.
    Swee LK; Tardivel A; Schneider P; Rolink A
    Immunol Lett; 2010 Jun; 131(1):40-8. PubMed ID: 20350570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and function of TNF family member B cell-activating factor in the development of autoimmune arthritis.
    Zhang M; Ko KH; Lam QL; Lo CK; Srivastava G; Zheng B; Lau YL; Lu L
    Int Immunol; 2005 Aug; 17(8):1081-92. PubMed ID: 16000326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway.
    Schiemann B; Gommerman JL; Vora K; Cachero TG; Shulga-Morskaya S; Dobles M; Frew E; Scott ML
    Science; 2001 Sep; 293(5537):2111-4. PubMed ID: 11509691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of a fusion protein of the extracellular domain of BR3 with the Fc fragment of human IgG1 (sBR3-Fc) in Pichia pastoris as an antagonist for BLyS.
    Cao P; Zhang S; Fang Z; Huang H; Bai P; Zhang Q; Luo C
    Appl Microbiol Biotechnol; 2008 Feb; 78(2):275-82. PubMed ID: 18189138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BAFF/BLyS receptor 3 binds the B cell survival factor BAFF ligand through a discrete surface loop and promotes processing of NF-kappaB2.
    Kayagaki N; Yan M; Seshasayee D; Wang H; Lee W; French DM; Grewal IS; Cochran AG; Gordon NC; Yin J; Starovasnik MA; Dixit VM
    Immunity; 2002 Oct; 17(4):515-24. PubMed ID: 12387744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel function of TNF cytokines in regulating bone marrow B cell survival.
    Zhang M; Ko KH; Lam QL; Lo CK; Xu DJ; Shen L; Zheng B; Srivastava G; Lu L
    Cell Mol Immunol; 2004 Dec; 1(6):447-53. PubMed ID: 16293214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF.
    Thompson JS; Bixler SA; Qian F; Vora K; Scott ML; Cachero TG; Hession C; Schneider P; Sizing ID; Mullen C; Strauch K; Zafari M; Benjamin CD; Tschopp J; Browning JL; Ambrose C
    Science; 2001 Sep; 293(5537):2108-11. PubMed ID: 11509692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of BAFF Blockade on Inflammation, Germinal Center Reaction and Effector B-Cells During Acute SIV Infection.
    Borhis G; Trovato M; Ibrahim HM; Isnard S; Le Grand R; Bosquet N; Richard Y
    Front Immunol; 2020; 11():252. PubMed ID: 32194549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of autoimmune hyperthyroidism in a murine model of Graves' disease with tumor necrosis factor-family ligand inhibitors suggests a key role for B cell activating factor in disease pathology.
    Gilbert JA; Kalled SL; Moorhead J; Hess DM; Rennert P; Li Z; Khan MZ; Banga JP
    Endocrinology; 2006 Oct; 147(10):4561-8. PubMed ID: 16794009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a novel receptor for B lymphocyte stimulator that is mutated in a mouse strain with severe B cell deficiency.
    Yan M; Brady JR; Chan B; Lee WP; Hsu B; Harless S; Cancro M; Grewal IS; Dixit VM
    Curr Biol; 2001 Oct; 11(19):1547-52. PubMed ID: 11591325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation and characterization of LymphoStat-B, a human monoclonal antibody that antagonizes the bioactivities of B lymphocyte stimulator.
    Baker KP; Edwards BM; Main SH; Choi GH; Wager RE; Halpern WG; Lappin PB; Riccobene T; Abramian D; Sekut L; Sturm B; Poortman C; Minter RR; Dobson CL; Williams E; Carmen S; Smith R; Roschke V; Hilbert DM; Vaughan TJ; Albert VR
    Arthritis Rheum; 2003 Nov; 48(11):3253-65. PubMed ID: 14613291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of BAFF and BAFF-R-Fc fusion protein in immune thrombocytopenia.
    Zhu XJ; Shi Y; Peng J; Guo CS; Shan NN; Qin P; Ji XB; Hou M
    Blood; 2009 Dec; 114(26):5362-7. PubMed ID: 19794139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic administration of belimumab, a BLyS antagonist, decreases tissue and peripheral blood B-lymphocyte populations in cynomolgus monkeys: pharmacokinetic, pharmacodynamic, and toxicologic effects.
    Halpern WG; Lappin P; Zanardi T; Cai W; Corcoran M; Zhong J; Baker KP
    Toxicol Sci; 2006 Jun; 91(2):586-99. PubMed ID: 16517838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BAFF AND APRIL: a tutorial on B cell survival.
    Mackay F; Schneider P; Rennert P; Browning J
    Annu Rev Immunol; 2003; 21():231-64. PubMed ID: 12427767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TACI:Fc scavenging B cell activating factor (BAFF) alleviates ovalbumin-induced bronchial asthma in mice.
    Moon EY; Ryu SK
    Exp Mol Med; 2007 Jun; 39(3):343-52. PubMed ID: 17603288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.